Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. 2005

P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
Department of Internal Medicine and Endocrine Sciences, Thoracic Surgery, Institute of Pathology, University of Perugia, Via E. Dal Pozzo, 06100 Perugia, Italy. pferolla@tin.it

Neuroendocrine tumors may occur in the setting of multiple endocrine neoplasia type 1 (MEN1) syndrome. Among these, a probably underestimated prevalence of well differentiated neuroendocrine thymic carcinoma (carcinoid), a neoplasm characterized by very aggressive behavior, has been described. We report characterization of the seven Italian cases in which this association occurred among a series of 221 MEN1 patients (41 sporadic and 180 familial cases; prevalence, 3.1%). All of the patients were male, and six of seven (85%) were heavy smokers. No associated hormonal hypersecretion was detected. The first diagnosis was between the second and fifth decades. Familial clusters were present in three of seven (42.8%). No genotype-phenotype correlation was found. All seven cases were associated with hyperparathyroidism. In one patient, prophylactic thymectomy revealed a small nodular lesion suggestive of a thymic carcinoid, providing evidence that preventive thymectomy might prevent additional growth of an occult thymic carcinoid. These findings confirm that thymic carcinoids are associated with a very high lethality, with a near-total prevalence in smoker males. Therefore, prophylactic thymectomy should be considered at neck surgery for primary hyperparathyroidism in MEN1 male patients, especially for smokers, and, due to the frequent familial clusters distribution of this pathology, in subjects with affected relatives presenting this feature. Thus, we recommend screening every patient affected with a neuroendocrine thymic neoplasm for MEN1 syndrome.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002276 Carcinoid Tumor A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182) Argentaffinoma,Carcinoid,Carcinoid, Goblet Cell,Argentaffinomas,Carcinoid Tumors,Carcinoids,Carcinoids, Goblet Cell,Goblet Cell Carcinoid,Goblet Cell Carcinoids,Tumor, Carcinoid,Tumors, Carcinoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013953 Thymus Neoplasms Tumors or cancer of the THYMUS GLAND. Cancer of Thymus,Thymus Cancer,Thymus Tumors,Cancer of the Thymus,Neoplasms, Thymic,Neoplasms, Thymus,Thymic Cancer,Thymic Neoplasms,Thymic Tumors,Cancer, Thymic,Cancer, Thymus,Cancers, Thymic,Cancers, Thymus,Neoplasm, Thymic,Neoplasm, Thymus,Thymic Cancers,Thymic Neoplasm,Thymic Tumor,Thymus Cancers,Thymus Neoplasm,Thymus Tumor,Tumor, Thymic,Tumor, Thymus,Tumors, Thymic,Tumors, Thymus
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission
D018761 Multiple Endocrine Neoplasia Type 1 A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13). Neoplasia, Multiple Endocrine Type 1,Neoplasms, Multiple Endocrine Type 1,Wermer Syndrome,Multiple Endocrine Neoplasia Type I,Multiple Endocrine Neoplasms Type 1,Neoplasms, Multiple Endocrine Type I

Related Publications

P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
January 2007, Journal of endocrinological investigation,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
June 2012, Kyobu geka. The Japanese journal of thoracic surgery,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
March 2013, Archivos de bronconeumologia,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
April 2023, Kyobu geka. The Japanese journal of thoracic surgery,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
January 2006, The Annals of thoracic surgery,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
September 2022, Endocrine,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
April 1990, The Western journal of medicine,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
October 2021, Cureus,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
January 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
P Ferolla, and A Falchetti, and P Filosso, and P Tomassetti, and G Tamburrano, and N Avenia, and G Daddi, and F Puma, and R Ribacchi, and F Santeusanio, and G Angeletti, and M L Brandi
November 1997, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!